Samantha Parker
Chief Patient Officer
Lysogene
Samantha Parker is Chief Patient Officer at Lysogene, with more than 20 years’ experience in the pharmaceutical industry: executive and management, strategic leadership, vice president of a foundation for independent professional education in rare diseases, global drug development & patient access across several rare disease therapeutic areas. She has been a member of the European Group of Experts on Rare Diseases (EGRD) and the International Rare Diseases Research Consortium (IRDiRC).